Table 1: Summary of the studies, where NMR spectroscopy has been applied to characterise lipids, presented in this review.
|
|
||
| Authors | Application | Reference |
|
|
||
| Ligand-Protein Interaction | ||
| de Vera et al. | Determination of Nurr1 protein conformations and interaction with binding fatty acids | 17,21 |
| Ragona et al. | Interaction between β-lactoglobuline and palmitic acid in a range of pHs | 24 |
| Patil et al. | Mechanism through which FABP1 mediates PPARα activation | 25 |
| Jones et al. | Interaction between arachidonic acid and odour binding protein 22 in Aedes Aegypti | 26 |
| 1H-NMR based lipidomics | ||
| Ouldamer et al. | Dose-dependent changes in polyunsaturated fatty acids in lipid extracts from adipose tissue | 27 |
| Chen et al. | Decrease of hepatic triglycerides, following a dietary intervention with leucine | 28 |
| Melvin et al. | Deregulation of membrane constituent-lipids and the accumulation of energy storage lipids in fish contaminated from metals and metalloids | 29 |
| Khandelwal et al. | Lipid classes in extracts from rodent furs following the administration of a stearoyl-CoA desaturase 1 inhibitor | 30 |
| 31P-NMR based lipidomics | ||
| Malmos et al. | Quantification of the different types of emulsifiers used for chocolate | 32 |
| Gouilleux et al. | Proposal and evaluation of two methods to measure absolute concentrations of phospholipids | 34 |
| Lipoprotein measures | ||
| Harbaum et al. | Lipoproteins association with outcomes in patients with idiopathic and heritable pulmonary arterial hypertension | 47 |
| Holmes et al. | Association of lipoproteins and other blood metabolites with risk of incident myocardial infarction, ischemic stroke and intracerebral haemorrhage | 48 |
| Sliz et al. | Comparison of lipoprotein profiles in cases of statin treatment and genetic inhibition of PCSK9 | 49 |
| Michielsen et al. | Comparison of lipoprotein profiles for diets with different fatty acids composition | 50 |
| Dias et al. | Comparison of lipoprotein profiles for diets rich in SFA and n-6PUFA, in people supplemented with eicosapentaenoic and docosahexaenoic acid | 51 |
| Sorokin et al. | Lipoprotein profiles in patients with psoriasis | 52 |
| Kostara et al. | Comparison of the composition of the HDL fractions in patients with low, normal or high HDL-cholesterol | 53 |
| Miranda et al. | Simultaneous characterization of the metabolic profiles in maternal and cord blood samples, to increase the knowledge about foetal growth restriction | 54 |
|
|
||